Clinical trial
A Randomized, Open-label, Assessor-blinded, Split-face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses
NCT00774787 is registered in ClinicalTrials.gov with Rigel Dermatology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label, Assessor-blinded, Split-face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses
- Lead sponsor
- Rigel Dermatology
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- March 31, 2010
- Enrollment
- 27 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratoses